492 related articles for article (PubMed ID: 28902875)
21. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
Hayashi T; Shimoyama N; Mizuno T
Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
[TBL] [Abstract][Full Text] [Related]
22. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
23. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
24. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
25. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
26. Sjögren's autoimmunity: how perturbation of recognition in endomembrane traffic may provoke pathological recognition at the cell surface.
Mircheff AK; Gierow JP; Yang T; Zhang J; Wood RL; Azzarolo AM; Warren DW; Zeng H; Guo Z; Kaslow HR; Hamm-Alvarez SF; Okamoto CT; Bachmann M
J Mol Recognit; 1998; 11(1-6):40-8. PubMed ID: 10076804
[TBL] [Abstract][Full Text] [Related]
27. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
28. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
Chaly Y; Barr JY; Sullivan DA; Thomas HE; Brodnicki TC; Lieberman SM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347820
[TBL] [Abstract][Full Text] [Related]
29. The protein kinase C system in focal adenitis of the lacrimal gland in the non-obese diabetic mouse model for Sjögren's syndrome.
Tensing EK; Törnwall J; Hukkanen M; Nordström DC; Konttinen YT
Acta Ophthalmol Scand; 2004 Oct; 82(5):569-73. PubMed ID: 15453855
[TBL] [Abstract][Full Text] [Related]
30. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
[TBL] [Abstract][Full Text] [Related]
31. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
32. Stimulation with carbachol alters endomembrane distribution and plasma membrane expression of intracellular proteins in lacrimal acinar cells.
Yang T; Zeng H; Zhang J; Okamoto CT; Warren DW; Wood RL; Bachmann M; Mircheff AK
Exp Eye Res; 1999 Dec; 69(6):651-61. PubMed ID: 10620394
[TBL] [Abstract][Full Text] [Related]
33. MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes.
Yang T; Zeng H; Zhang J; Okamoto CT; Warren DW; Wood RL; Bachmann M; Mircheff AK
Am J Physiol; 1999 Nov; 277(5):C994-C1007. PubMed ID: 10564093
[TBL] [Abstract][Full Text] [Related]
34. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
Sullivan DA; Edwards JA
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
[TBL] [Abstract][Full Text] [Related]
35. Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Atkinson R; Trousdale MD
Cornea; 2003 Jan; 22(1):25-32. PubMed ID: 12502944
[TBL] [Abstract][Full Text] [Related]
36. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
38. Blocking IAg
Gupta S; Li D; Ostrov DA; Nguyen CQ
Life Sci; 2022 Jan; 288():120182. PubMed ID: 34843735
[TBL] [Abstract][Full Text] [Related]
39. Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.
Gilbard JP; Hanninen LA; Rothman RC; Kenyon KR
Curr Eye Res; 1987 Oct; 6(10):1237-48. PubMed ID: 3677784
[TBL] [Abstract][Full Text] [Related]
40. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]